AGORACOM Small-cap Investor Relations Blog

• October 2017 sales as reported by the Company were C$1,313,653
• Representing a 1% month-on-month increase and a 174% year-on-year increase in comparison with September 2017 and October 2016, respectively

VANCOUVER, British Columbia, Nov. 08, 2017 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce October 2017 unaudited sales as reported by the Company (including shipping revenues after discounts and refunds) were C$1,313,653 representing a 1% month-on-month increase and a 174% year-on-year increase in comparison with September 2017 and October 2016, respectively. The Company is also pleased to announce that it has submitted an amendment to its application with Health Canada for its wholly owned subsidiary Cannmart Inc. (“CannMart”) to include the sale of medical cannabis oils.

The table below displays a breakdown of Namaste’s revenue by sales channel.

While Namaste continues to see strong revenue leading in to the holiday season, the Company has also made substantial progress with CannMart, having now submitted an amendment on its application to include a license for the sale of cannabis oils under the Canadian Access to Cannabis for Medical Purposes Regulations (“ACMPR”) program. Construction of the CannMart facility will commence in late November, 2017 and the Company estimates a 6-8 week turnaround time for completion.

Namaste’s Canadian business represents approximately 5.5% of the Company’s total revenue and includes a consumer database of over 11,000 people with an average of 30,000 site visits per month. Namaste plans to leverage its data through CannMart to become Canada’s premiere online retailer for medical cannabis. The Company intends to pursue similar opportunities in other territories in which the Company maintains a large market share of cannabis users. Further to the Company’s joint press release dated November 7, 2017, Namaste has seen positive results in terms of vaporizer sales in a medical cannabis platform. These results further validate the Company’s intention of creating and leveraging a globally diversified database of cannabis users.

Management Commentary
Sean Dollinger, President and CEO of Namaste, comments: “We are very pleased not only to announce strong sales figures for October 2017, but also to provide these important updates on CannMart. The amended application to include the sale of cannabis oils is a crucial part of our plan to become Canada’s leading online retailer for medical cannabis products. As Namaste is already the largest global retailer of vaporizers products and accessories, we truly understand the need for patients to have access to a variety of consumption devices for dried flower as well as oils and we believe that medical patients should be offered a larger variety of product sourced from multiple licensed producers. We are very much looking forward to receiving our distribution license and have high expectations for this as a new revenue vertical for the Company.”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, US, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
+1 (786) 389 9771
Email: [email protected]

Further information on the Company and its products can be accessed through the links below:
www.namastetechnologies.com
www.namastevaporizers.com
www.namastevaporizers.co.uk
www.everyonedoesit.com
www.everyonedoesit.co.uk

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.